9 | $AUMN 22% v4,7M c2.33 f8,573M Hod2.44 | znewcar1 | 10/23/2023 10:52:47 PM |
8 | $AUMN 49% v3,0M c1.90 f8,573M Hod1.94 ML.6 | znewcar1 | 10/20/2023 4:10:04 PM |
7 | $AUMN 47% c3,9M c1.36 f8,573M Hod1.55 ml.6 | znewcar1 | 10/18/2023 4:19:38 PM |
6 | AUMN 12% v1,544,603 c.44 162,8M04,612 | znewcar1 | 01/19/2022 5:50:28 PM |
5 | AUMN Stock year to date has changed -14.81% | Jake13 | 04/29/2015 3:45:57 PM |
4 | AUMN 0.46 Golden Minerals Co. Stock Charts $AUMN | chartguy89 | 04/29/2015 3:42:12 PM |
3 | AUMN 0.67 Golden Minerals Co. Stock Charts $AUMN | chartguy89 | 11/17/2014 11:14:07 PM |
2 | AUMN Year to date has changed +42.55% percent. | Jake13 | 11/17/2014 11:07:47 PM |
1 | Golden Minerals Company (AUMN) Keep a close eye | riddock57 | 02/28/2014 5:10:46 AM |
Recent Articles
- Samsung Chairman's Family Sells Shares to Meet Inheritance Tax
- Clinical Breakthrough: ITM's Promising Trial Results Unveiled
- Celcuity's Promising Phase 1 Trial Results on Prostate Cancer Therapy
- New Findings on Gedatolisib’s Efficacy for Advanced Breast Cancer
- Concerns Raised Over Elon Musk's Striking Compensation Package
- Qustodio: Elevating Digital Child Safety on iPhones in 2025
- Celcuity's Phase 3 VIKTORIA-1 Trial for PIK3CA Mutants Advances
- Innovative Gedatolisib and Darolutamide Study Shows Promise
- New Insights on Gedatolisib's Role in Breast Cancer Treatment
- Meta and Blue Owl Collaborate on $30 Billion AI Data Center
- Kura Oncology's Latest Insights on FTI Program Advancements
- Nvidia's Market Share Plummets: CEO Jensen Huang's Concerns
- Kura Oncology Unveils Promising Data from FTI Programs at ESMO
- Olema Oncology Shares Promising Findings on Palazestrant
- General Oncology's SHARON Trial Yields Encouraging Results
- Revitalizing ER+ Breast Cancer with Palazestrant and Ribociclib
- Corbus Pharmaceuticals Reports Promising Results for CRB-701
- Promising Data on NX-1607: A Breakthrough in Cancer Treatment
- Florida Cancer Specialists Revolutionizing Oncology Research
- Salesforce CEO's Apology Sparks Controversy in Tech Industry
- Significant Progress in Advanced Breast Cancer Treatments with Giredestrant
- Breakthrough in HPV Carcinoma Treatment by SCG Cell Therapy
- Innovative Immunotherapy SCG142 Shows Promise in Cancer Treatment
- Trump's Decision on Ukraine Missiles Revealed After Key Talks
- Kevin O'Leary Highlights Importance of American Dream for Leadership
- Transformational Program for Millennial Professionals Unveiled
- Investigation Launched as PeopleGuru Faces Data Breach Crisis
- Trump Seeks Supreme Court Approval for National Guard in Chicago
- Westhaven Gold Corp. Announces Executive Update and Future Plans
- Trump Commutes Santos' Prison Sentence Amid Public Support
- A New Toolkit to Enhance Executive Function Skills in Education
- Westhaven Gold Announces Leadership Changes and Operations Update
- Aeroméxico's Exciting Global Offering: What You Need to Know
- Investigation Into Luminar Technologies Signals Serious Concerns
- Inquiry into Hasbro Leadership: Legal Investigation Unfolds
- Legal Investigation of CVS/Aetna Medicare Advantage Claims
- Deadline Approaches for Dow Investors in Class Action Case
- Investors Alert: Key Class Action Lawsuit Against V.F. Corporation
- Fluor Corporation Lawsuit Update: Important Investor Info
- Investors Urged to Act Before KBR Class Action Deadline
- Cytokinetics Class Action Lawsuit Update: Important Deadlines
- Important Legal Update for WPP Investors: Key Deadline Approaches
- Molina Healthcare Faces Class Action Lawsuit Amid Financial Turmoil
- Marex Group Faces Class Action Lawsuit Over Financial Misconduct
- Lead the Charge: Join the Fly-E Group Securities Lawsuit
- Investigation into MoonLake Immunotherapeutics Raises Concerns
- MoonLake Immunotherapeutics: Investors Investigate Potential Fraud
- Investigation of MoonLake Immunotherapeutics Raises Concerns
- Leadership Changes at Silver Mountain Resources: What to Expect
- Canton Fair Launches Enhanced Services to Boost Global Trade